Cara Therapeutics, Inc. (0HTC.L) LSE
15.99
-0.7893(-4.70%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
15.99
-0.7893(-4.70%)
Currency In USD
| Market Cap | 31.9M |
| Enterprise Value | 11.37M |
| P/E Ratio | -2.01 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 11.03 |
| Price/Book Ratio | 1.3 |
| Enterprise/Revenue | 3.04 |
| Enterprise/EBITDA | -0.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -5.27 |
| Operating Margin | -10.41 |
| Return On Assets | -0.42 |
| Return On Equity | -0.81 |
| Revenue | 0 |
| Revenue/Share | 0.29 |
| Gross Profit | 0 |
| EBITDA | -26.65M |
| Net Income | -18.21M |
| Diluted EPS | -3.26 |
| Total Cash | 30.81M |
| Total Cash/Share | 3.43 |
| Total Debt | 201,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 2.86 |
| Book Value Per Share | 2.33 |
| 52-Week Change | 359.48 |
| 52-Week High | 15.99 |
| 52-Week Low | 0.5 |
| Moving Average 50 Days | 0.69 |
| Moving Average 200 Days | 1.89 |
| Average Volume | 18,632 |
| Shares Outstanding | 1.52M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 83333:1000000 |
| Last Split Date | December 31, 2024 |